In the context of breast cancer, the authors suggest that the inhibition of proline catabolism via PRODH1 targeting affects cancer cells' ability to establish metastasis most likely by impeding a phenotypic shift cancer cells need to operate at the first stage of micrometastasis formation once they have colonized the distant organ. The gene discussed is PRODH; the disease is cancer.